Skip to main content
GutCited

Bifidobacterium bifidum Functional Dyspepsia

C

B. bifidum YIT 10347 showed improvement in acid-related and gas-related dyspepsia symptoms in Japanese studies. Mixed results in Western populations.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dbifidobacterium\u002Dbifidum\u0026condition\u003Dfunctional\u002Ddyspepsia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

結論

B. bifidum YIT 10347 showed improvement in acid-related and gas-related dyspepsia symptoms in Japanese studies. Mixed results in Western populations.

Key Study Findings

Controlled Clinical Trial n=54 3.0 weeks
[Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with …
Dose: 350 mg vs: None Outcome: IBS symptom improvement 効果: None None

対象集団: Irritable bowel syndrome with diarrhea and antibiotic-associated diarr

Randomized Controlled Trial n=100 4 weeks Double-blind
Bifidobacterium bifidum YIT 10347 fermented milk exerts beneficial effects on gastrointestinal discomfort and symptoms in …
Dose: 100 mL/day fermented milk vs: Placebo fermented milk Outcome: GI symptom scores (m-FSSG, GSRS) 効果: None None

対象集団: Healthy Japanese adults with GI discomfort

Randomized Controlled Trial Double-blind
Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or …
Dose: None vs: Placebo + eradication regimen Outcome: H. pylori eradication rate and adverse effects 効果: None None

対象集団: Adults with H. pylori infection

Key Statistics

4

研究数

500

参加者数

Positive

C

グレード

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
1-10 billion CFU/day
dyspepsiasupport:
1 billion CFU/day (YIT 10347 strain)

上限量: Well-tolerated up to 10 billion CFU/day in clinical trials

研究で検討された用量

用量 期間 効果 N
350 mg 3.0 weeks Positive 54
100 mL/day fermented milk 4 weeks Positive 100
100 mL/day 4.0 weeks Positive --
None -- Neutral --

推奨摂取タイミング: On an empty stomach or before meals

Safety & Side Effects

報告されている副作用

  • Mild gas and bloating during initial use
  • Occasional abdominal discomfort
  • Rare loose stools
  • Very rare: bacteremia in immunocompromised individuals

既知の相互作用

  • Antibiotics (may reduce probiotic viability; space dosing 2 hours apart)
  • Immunosuppressants (use with caution in immunocompromised patients)

耐容上限摂取量: Well-tolerated up to 10 billion CFU/day in clinical trials

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Bifidobacterium bifidum help with Functional Dyspepsia?
Based on 4 studies with 500 participants, there is limited but promising evidence that Bifidobacterium bifidum may support Functional Dyspepsia management. Our evidence grade is C (Some Evidence).
How much Bifidobacterium bifidum should I take for Functional Dyspepsia?
Studies have used various dosages. A commonly studied range is 1-10 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Bifidobacterium bifidum?
Reported side effects may include Mild gas and bloating during initial use, Occasional abdominal discomfort, Rare loose stools, Very rare: bacteremia in immunocompromised individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Bifidobacterium bifidum and Functional Dyspepsia?
We rate the evidence as Grade C (Some Evidence). This rating is based on 4 peer-reviewed studies with 500 total participants. The overall direction of effect is positive.

Related Evidence

に関する他の成分: Functional Dyspepsia

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。